139 related articles for article (PubMed ID: 33359543)
1. Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis.
Abe K; Chiba Y; Katsuse O; Takahashi Y; Suda A; Hattori S; Yoshimi R; Kirino Y; Kunii M; Yoshimi A; Asami T; Hishimoto A
Neurosci Lett; 2021 Jan; 743():135588. PubMed ID: 33359543
[TBL] [Abstract][Full Text] [Related]
2. H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay.
Iizuka M; Nagata N; Kanazawa N; Iwami T; Nagashima M; Nakamura M; Kaneko J; Kitamura E; Nishiyama K; Mamorita N; Iizuka T
Front Immunol; 2024; 15():1350837. PubMed ID: 38745654
[TBL] [Abstract][Full Text] [Related]
3. An exploratory investigation of antibodies to NMDA-type glutamate receptor subunits in serum and cerebrospinal fluid among psychiatric patients with anti-thyroid antibodies.
Saito T; Chiba Y; Abe K; Hattori S; Katsuse O; Takahashi Y; Suda A
Heliyon; 2020 Dec; 6(12):e05677. PubMed ID: 33319115
[TBL] [Abstract][Full Text] [Related]
4. Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size.
Kalev-Zylinska ML; Symes W; Little KC; Sun P; Wen D; Qiao L; Young D; During MJ; Barber PA
Stroke; 2013 Aug; 44(8):2212-9. PubMed ID: 23723305
[TBL] [Abstract][Full Text] [Related]
5. A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis.
Najjar S; Steiner J; Najjar A; Bechter K
J Neuroinflammation; 2018 Feb; 15(1):40. PubMed ID: 29433523
[TBL] [Abstract][Full Text] [Related]
6. Neuronal autoantibodies associated with cognitive impairment in melanoma patients.
Bartels F; Strönisch T; Farmer K; Rentzsch K; Kiecker F; Finke C
Ann Oncol; 2019 May; 30(5):823-829. PubMed ID: 30840061
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.
Tong J; Huang J; Luo X; Chen S; Cui Y; An H; Xiu M; Tan S; Wang Z; Yuan Y; Zhang J; Yang F; Li CR; Hong LE; Tan Y
Brain Behav Immun; 2019 Oct; 81():213-219. PubMed ID: 31201848
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the concordance between GluN1-GluN2 heteromer live-cell-based assay and GluN1 monomer biochip kit assay on anti-NMDAR autoantibody detection.
Tanaka K; Kitagawa Y; Hori K; Kinoshita M; Tanaka M
J Immunol Methods; 2021 Dec; 499():113150. PubMed ID: 34560071
[TBL] [Abstract][Full Text] [Related]
10. Anti-neuronal anti-bodies in patients with early psychosis.
Mantere O; Saarela M; Kieseppä T; Raij T; Mäntylä T; Lindgren M; Rikandi E; Stoecker W; Teegen B; Suvisaari J
Schizophr Res; 2018 Feb; 192():404-407. PubMed ID: 28461116
[TBL] [Abstract][Full Text] [Related]
11. Anti-NMDA receptor antibody positivity in acute psychotic states: An exploratory study.
Bharadwaj B; Sathyanarayanan G; Kaliaperumal V; Dhodapkar R
Asian J Psychiatr; 2019 Jun; 43():95-98. PubMed ID: 31121536
[TBL] [Abstract][Full Text] [Related]
12. Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice.
Yue W; Caldwell S; Risbrough V; Powell S; Zhou X
PLoS One; 2021; 16(9):e0256972. PubMed ID: 34473764
[TBL] [Abstract][Full Text] [Related]
13. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome.
Fukuyama T; Takahashi Y; Kubota Y; Mogami Y; Imai K; Kondo Y; Sakuma H; Tominaga K; Oguni H; Nishimura S
Epilepsy Res; 2015 Jul; 113():34-43. PubMed ID: 25986190
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis.
Green TN; Hamilton JR; Morel-Kopp MC; Zheng Z; Chen TT; Hearn JI; Sun PP; Flanagan JU; Young D; Barber PA; During MJ; Ward CM; Kalev-Zylinska ML
Platelets; 2017 Dec; 28(8):799-811. PubMed ID: 28277064
[TBL] [Abstract][Full Text] [Related]
15. Anti-NR2 glutamate receptor antibodies as an early biomarker of cerebral small vessel disease.
Dobrynina LA; Alexandrova EV; Zabitova MR; Kalashnikova LA; Krotenkova MV; Akhmetzyanov BM
Clin Biochem; 2021 Oct; 96():26-32. PubMed ID: 34245693
[TBL] [Abstract][Full Text] [Related]
16. Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology.
Dubey D; Alqallaf A; Hays R; Freeman M; Chen K; Ding K; Agostini M; Vernino S
JAMA Neurol; 2017 Apr; 74(4):397-402. PubMed ID: 28166327
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias.
Busse S; Brix B; Kunschmann R; Bogerts B; Stoecker W; Busse M
Neurosci Res; 2014 Aug; 85():58-64. PubMed ID: 24973618
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease.
Ehrenreich H
Curr Opin Neurol; 2018 Jun; 31(3):306-312. PubMed ID: 29474316
[TBL] [Abstract][Full Text] [Related]
19. Detection of autoantibody against extracellular epitopes of N-methyl-D-aspartate receptor by cell-based assay.
Takano S; Takahashi Y; Kishi H; Taguchi Y; Takashima S; Tanaka K; Muraguchi A; Mori H
Neurosci Res; 2011 Nov; 71(3):294-302. PubMed ID: 21839784
[TBL] [Abstract][Full Text] [Related]
20. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
